Autoreactive CD8 T cells in NOD mice exhibit phenotypic heterogeneity but restricted TCR gene usage.
Moujtaba Y KasmaniAshley E CieckoAshley K BrownGalina PetrovaJack GorskiYi-Guang ChenWeiguo CuiPublished in: Life science alliance (2022)
Type 1 diabetes (T1D) is an autoimmune disorder defined by CD8 T cell-mediated destruction of pancreatic β cells. We have previously shown that diabetogenic CD8 T cells in the islets of non-obese diabetic mice are phenotypically heterogeneous, but clonal heterogeneity remains relatively unexplored. Here, we use paired single-cell RNA and T-cell receptor sequencing (scRNA-seq and scTCR-seq) to characterize autoreactive CD8 T cells from the islets and spleens of non-obese diabetic mice. scTCR-seq demonstrates that CD8 T cells targeting the immunodominant β-cell epitope IGRP 206-214 exhibit restricted TCR gene usage. scRNA-seq identifies six clusters of autoreactive CD8 T cells in the islets and six in the spleen, including memory and exhausted cells. Clonal overlap between IGRP 206-214 -reactive CD8 T cells in the islets and spleen suggests these cells may circulate between the islets and periphery. Finally, we identify correlations between TCR genes and T-cell clonal expansion and effector fate. Collectively, our work demonstrates that IGRP 206-214 -specific CD8 T cells are phenotypically heterogeneous but clonally restricted, raising the possibility of selectively targeting these TCR structures for therapeutic benefit.
Keyphrases
- single cell
- rna seq
- genome wide
- induced apoptosis
- type diabetes
- regulatory t cells
- cell cycle arrest
- high throughput
- dna methylation
- adipose tissue
- metabolic syndrome
- endoplasmic reticulum stress
- oxidative stress
- signaling pathway
- cardiovascular disease
- stem cells
- dendritic cells
- cancer therapy
- bariatric surgery
- gene expression
- cell therapy
- nk cells